These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8792069)

  • 21. Granulocyte colony-stimulating factor and other cytokines in antifungal therapy.
    Roilides E; Farmaki E
    Clin Microbiol Infect; 2001; 7 Suppl 2():62-7. PubMed ID: 11525220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid colony-stimulating factors: use in the newborn.
    Sreenan C; Osiovich H
    Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.
    Hustinx W; Benaissa-Trouw B; Van Kessel K; Kuenen J; Tavares L; Kraaijeveld K; Verhoef J; Hoepelman A
    Eur J Clin Invest; 1997 Dec; 27(12):1044-8. PubMed ID: 9466134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy and immunoprophylaxis in bone marrow transplantation.
    Barnes RA
    J Hosp Infect; 1995 Jun; 30 Suppl():223-31. PubMed ID: 7560954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of agranulocytosis and sepsis with granulocyte colony stimulating factor in a case of Felty's syndrome.
    Marfeuille M; Clerc D; Mariette X
    J Rheumatol; 1995 Sep; 22(9):1803-4. PubMed ID: 8523369
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of granulocyte-colony stimulating factor on the polymorphonuclear leukocyte activity and the course of sepsis in rats with experimental peritonitis.
    Gurleyik G; Yanikkaya G; Gurleyik E; Ozturk E; Dulundu E; Saglam A
    Surg Today; 2007; 37(5):401-5. PubMed ID: 17468822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difference in the responses after administration of granulocyte colony-stimulating factor in septic patients with relative neutropenia.
    Ishikawa K; Tanaka H; Nakamori Y; Hosotsubo H; Ogura H; Nishino M; Shimazu T; Sugimoto H
    J Trauma; 2000 May; 48(5):814-24; discussion 824-5. PubMed ID: 10823524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
    Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
    Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life.
    Rosenthal J; Healey T; Ellis R; Gillan E; Cairo MS
    J Pediatr; 1996 Jan; 128(1):135-7. PubMed ID: 8551404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of rhG-CSF on neutrophil functions and survival in sepsis induced diabetic rats.
    Cantürk Z; Cantürk NZ; Onen F
    Endocr Res; 1998 May; 24(2):141-57. PubMed ID: 9738693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor.
    Torossian A; Ruehlmann S; Middeke M; Sessler DI; Lorenz W; Wulf HF; Bauhofer A
    Anesthesiology; 2003 Nov; 99(5):1087-92. PubMed ID: 14576544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice.
    Sheibani N; Grabowski EF; Schoenfeld DA; Whalen MJ
    Crit Care Med; 2004 Nov; 32(11):2274-8. PubMed ID: 15640641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and management of infections complicated with hematological diseases].
    Toyama K
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1485-90. PubMed ID: 1722236
    [No Abstract]   [Full Text] [Related]  

  • 36. Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances.
    Skirecki T; Borkowska-Zielińska U; Złotorowicz M; Hoser G
    Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):123-35. PubMed ID: 22301668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Reising S; Repasky EA; Czuczman MS
    Leuk Lymphoma; 2005 Dec; 46(12):1775-84. PubMed ID: 16263581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on neutrophil formation and function.
    Khwaja A; Linch DC
    Curr Opin Hematol; 1994 May; 1(3):216-20. PubMed ID: 9371285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.